• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与儿童非酒精性脂肪性肝病患者的脂肪性肝炎和中重度纤维化相关的微生物组特征。

Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.

机构信息

Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, La Jolla, California; Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, California.

The Jackson Laboratory for Genomic Medicine, Farmington, Connecticut.

出版信息

Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.

DOI:10.1053/j.gastro.2019.06.028
PMID:31255652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6756995/
Abstract

BACKGROUND & AIMS: The intestinal microbiome might affect the development and severity of nonalcoholic fatty liver disease (NAFLD). We analyzed microbiomes of children with and without NAFLD.

METHODS

We performed a prospective, observational, cross-sectional study of 87 children (age range, 8-17 years) with biopsy-proven NAFLD and 37 children with obesity without NAFLD (controls). Fecal samples were collected and microbiome composition and functions were assessed using 16S ribosomal RNA amplicon sequencing and metagenomic shotgun sequencing. Microbial taxa were identified using zero-inflated negative binomial modeling. Genes contributing to bacterial pathways were identified using gene set enrichment analysis.

RESULTS

Fecal microbiomes of children with NAFLD had lower α-diversity than those of control children (3.32 vs 3.52, P = .016). Fecal microbiomes from children with nonalcoholic steatohepatitis (NASH) had the lowest α-diversity (control, 3.52; NAFLD, 3.36; borderline NASH, 3.37; NASH, 2.97; P = .001). High abundance of Prevotella copri was associated with more severe fibrosis (P = .036). Genes for lipopolysaccharide biosynthesis were enriched in microbiomes from children with NASH (P < .001). Classification and regression tree model with level of alanine aminotransferase and relative abundance of the lipopolysaccharide pathway gene encoding 3-deoxy-d-manno-octulosonate 8-phosphate-phosphatase identified patients with NASH with an area under the receiver operating characteristic curve value of 0.92. Genes involved in flagellar assembly were enriched in the fecal microbiomes of patients with moderate to severe fibrosis (P < .001). Classification and regression tree models based on level of alanine aminotransferase and abundance of genes encoding flagellar biosynthesis protein had good accuracy for identifying case children with moderate to severe fibrosis (area under the receiver operating characteristic curve, 0.87).

CONCLUSIONS

In an analysis of fecal microbiomes of children with NAFLD, we associated NAFLD and NASH with intestinal dysbiosis. NAFLD and its severity were associated with greater abundance of genes encoding inflammatory bacterial products. Alterations to the intestinal microbiome might contribute to the pathogenesis of NAFLD and be used as markers of disease or severity.

摘要

背景与目的

肠道微生物群可能会影响非酒精性脂肪性肝病(NAFLD)的发生和严重程度。我们分析了患有和不患有 NAFLD 的儿童的微生物组。

方法

我们对 87 名经活检证实患有 NAFLD 的儿童(年龄 8-17 岁)和 37 名患有非酒精性脂肪肝的肥胖儿童(对照组)进行了前瞻性、观察性、横断面研究。收集粪便样本,使用 16S 核糖体 RNA 扩增子测序和宏基因组鸟枪法测序评估微生物组组成和功能。使用零膨胀负二项式模型鉴定微生物分类群。使用基因集富集分析鉴定与细菌途径相关的基因。

结果

患有 NAFLD 的儿童的粪便微生物组的 α-多样性低于对照组儿童(3.32 对 3.52,P=0.016)。非酒精性脂肪性肝炎(NASH)患儿的粪便微生物组的 α-多样性最低(对照组 3.52;NAFLD 3.36;边缘性 NASH 3.37;NASH 2.97;P=0.001)。Prevotella copri 的丰度与更严重的纤维化相关(P=0.036)。NASH 患儿的微生物组中富含脂多糖生物合成基因(P<0.001)。基于丙氨酸氨基转移酶水平和内毒素途径基因相对丰度的分类和回归树模型,可识别出 NASH 患者,其受试者工作特征曲线下面积值为 0.92。在中重度纤维化患者的粪便微生物组中,富集了参与鞭毛组装的基因(P<0.001)。基于丙氨酸氨基转移酶水平和编码鞭毛生物合成蛋白的基因丰度的分类和回归树模型,对中重度纤维化患者的识别具有良好的准确性(受试者工作特征曲线下面积,0.87)。

结论

在对患有 NAFLD 的儿童的粪便微生物组进行分析时,我们将 NAFLD 和 NASH 与肠道菌群失调相关联。NAFLD 及其严重程度与编码炎症性细菌产物的基因丰度增加有关。肠道微生物组的改变可能有助于 NAFLD 的发病机制,并可作为疾病或严重程度的标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/89723aaba9b6/nihms-1532962-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/d10772482989/nihms-1532962-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/b58ea33220a3/nihms-1532962-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/dd022883ea33/nihms-1532962-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/04de891f92e5/nihms-1532962-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/89723aaba9b6/nihms-1532962-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/d10772482989/nihms-1532962-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/b58ea33220a3/nihms-1532962-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/dd022883ea33/nihms-1532962-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/04de891f92e5/nihms-1532962-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c137/6756995/89723aaba9b6/nihms-1532962-f0005.jpg

相似文献

1
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.与儿童非酒精性脂肪性肝病患者的脂肪性肝炎和中重度纤维化相关的微生物组特征。
Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.
2
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道菌群失调。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5.
3
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.非酒精性脂肪性肝病的严重程度与肠道菌群失调及肠道微生物群代谢功能的改变有关。
Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.
4
Lower gut microbiome diversity and higher abundance of proinflammatory genus are associated with biopsy-proven nonalcoholic steatohepatitis.下消化道微生物多样性降低和促炎属的丰度增加与活检证实的非酒精性脂肪性肝炎有关。
Gut Microbes. 2020 May 3;11(3):569-580. doi: 10.1080/19490976.2019.1681861. Epub 2019 Nov 7.
5
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.台湾经活检证实的非酒精性脂肪性肝病患者的肠道微生物失调:一项横断面研究。
Nutrients. 2020 Mar 19;12(3):820. doi: 10.3390/nu12030820.
6
Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease.肠道病毒组特征与非酒精性脂肪性肝病严重程度相关。
Gastroenterology. 2020 Nov;159(5):1839-1852. doi: 10.1053/j.gastro.2020.07.005. Epub 2020 Jul 9.
7
Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.肠道菌群在儿童非酒精性脂肪性肝病发病机制中的作用。
Microbiol Spectr. 2024 Feb 6;12(2):e0100623. doi: 10.1128/spectrum.01006-23. Epub 2024 Jan 8.
8
Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.伊朗非酒精性脂肪性肝病和非酒精性脂肪性肝炎患者肠道微生物组组成的特征。
Sci Rep. 2023 Nov 23;13(1):20584. doi: 10.1038/s41598-023-47905-z.
9
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.基于肠道微生物群的宏基因组特征用于非侵入性检测人类非酒精性脂肪性肝病中的晚期纤维化
Cell Metab. 2017 May 2;25(5):1054-1062.e5. doi: 10.1016/j.cmet.2017.04.001.
10
Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.非酒精性脂肪性肝炎(NASH)瘦患者的肠道微生物群组成与肝损伤相关,且独立于热量摄入:一项前瞻性试点研究。
Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):369-384. doi: 10.1016/j.numecd.2017.10.014. Epub 2017 Oct 26.

引用本文的文献

1
Unraveling the gut-immune-kidney axis in kidney stone disease: a two-step Mendelian randomization investigation.解析肾结石疾病中的肠道-免疫-肾脏轴:一项两步孟德尔随机化研究
Urolithiasis. 2025 Aug 20;53(1):160. doi: 10.1007/s00240-025-01830-0.
2
Lactiplantibacillus plantarum attenuate gossypol-induced hepatic lipotoxicity by altering intestinal microbiota for enriching microbial tryptophan metabolites in Nile tilapia (Oreochromis niloticus).植物乳杆菌通过改变尼罗罗非鱼(Oreochromis niloticus)的肠道微生物群以富集微生物色氨酸代谢物来减轻棉酚诱导的肝脏脂毒性。
Microbiome. 2025 Aug 4;13(1):180. doi: 10.1186/s40168-025-02172-0.
3

本文引用的文献

1
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.非酒精性脂肪性肝病相关肝硬化的肠道微生物组特征。
Nat Commun. 2019 Mar 29;10(1):1406. doi: 10.1038/s41467-019-09455-9.
2
Microbiome Datasets Are Compositional: And This Is Not Optional.微生物组数据集具有构成性:这并非可有可无。
Front Microbiol. 2017 Nov 15;8:2224. doi: 10.3389/fmicb.2017.02224. eCollection 2017.
3
Stress and stability: applying the Anna Karenina principle to animal microbiomes.压力与稳定:应用《安娜·卡列尼娜》原则于动物微生物组。
Understanding crosstalk between the gut and liver microbiome: pathogenesis to therapeutic approaches in liver cancer.
了解肠道和肝脏微生物群之间的串扰:肝癌的发病机制与治疗方法
Cancer Cell Int. 2025 Jul 29;25(1):291. doi: 10.1186/s12935-025-03840-9.
4
The Association Between and Advanced Fibrosis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease.代谢功能障碍相关脂肪性肝病进展过程中[具体内容缺失]与晚期肝纤维化的关联。
Nutrients. 2025 Jun 27;17(13):2145. doi: 10.3390/nu17132145.
5
Gut microbiota links to histological damage in chronic HBV infection patients and aggravates fibrosis via fecal microbiota transplantation in mice.肠道微生物群与慢性乙型肝炎病毒感染患者的组织学损伤相关,并通过小鼠粪便微生物群移植加重纤维化。
Microbiol Spectr. 2025 Aug 5;13(8):e0076425. doi: 10.1128/spectrum.00764-25. Epub 2025 Jul 11.
6
Gut microbiome in metabolic dysfunction-associated steatotic liver disease and associated hepatocellular carcinoma.代谢功能障碍相关脂肪性肝病及相关肝细胞癌中的肠道微生物群
Nat Rev Gastroenterol Hepatol. 2025 Jul 7. doi: 10.1038/s41575-025-01089-1.
7
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics.非酒精性脂肪性肝病中的肠道微生物群:病理生理学、诊断与治疗
World J Hepatol. 2025 Jun 27;17(6):106849. doi: 10.4254/wjh.v17.i6.106849.
8
Impact of Gut Microbiome on Gut Permeability in Liver and Gut Diseases.肠道微生物群对肝脏和肠道疾病中肠道通透性的影响。
Microorganisms. 2025 May 23;13(6):1188. doi: 10.3390/microorganisms13061188.
9
Blood bacterial DNA signatures in a prospective cohort of patients with MASLD cirrhosis.非酒精性脂肪性肝炎肝硬化患者前瞻性队列中的血液细菌DNA特征
Hepatol Commun. 2025 Jun 9;9(7). doi: 10.1097/HC9.0000000000000722. eCollection 2025 Jul 1.
10
Meta-analysis of shotgun sequencing of gut microbiota in obese children with MASLD or MASH.对患有MASLD或MASH的肥胖儿童肠道微生物群进行鸟枪法测序的荟萃分析。
Gut Microbes. 2025 Dec;17(1):2508951. doi: 10.1080/19490976.2025.2508951. Epub 2025 May 21.
Nat Microbiol. 2017 Aug 24;2:17121. doi: 10.1038/nmicrobiol.2017.121.
4
Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道菌群失调。
Hepatobiliary Pancreat Dis Int. 2017 Aug 15;16(4):375-381. doi: 10.1016/S1499-3872(17)60019-5.
5
Sequencing the gut metagenome as a noninvasive diagnosis for advanced nonalcoholic steatohepatitis.
Hepatology. 2017 Dec;66(6):2080-2083. doi: 10.1002/hep.29387. Epub 2017 Oct 30.
6
Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.辅助性T细胞17参与非酒精性脂肪性肝病进展为非酒精性脂肪性肝炎。
World J Gastroenterol. 2016 Nov 7;22(41):9096-9103. doi: 10.3748/wjg.v22.i41.9096.
7
Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患儿的糖尿病前期和2型糖尿病患病率
JAMA Pediatr. 2016 Oct 3;170(10):e161971. doi: 10.1001/jamapediatrics.2016.1971.
8
Diet-microbiota interactions as moderators of human metabolism.饮食与微生物群的相互作用作为人类新陈代谢的调节因素
Nature. 2016 Jul 7;535(7610):56-64. doi: 10.1038/nature18846.
9
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine.肠道菌群失调通过激活肠道自身反应性 T 细胞促进关节炎的发生。
Arthritis Rheumatol. 2016 Nov;68(11):2646-2661. doi: 10.1002/art.39783.
10
Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach.采用综合宏基因组学方法分析小儿非酒精性脂肪肝和肥胖患者的肠道微生物组。
Hepatology. 2017 Feb;65(2):451-464. doi: 10.1002/hep.28572. Epub 2016 Jun 2.